# Haloperidol Prophylaxis in Cardiac Surgery for Patients at Risk for Delirium

> **NCT01862302** · PHASE3 · COMPLETED · sponsor: **McMaster University** · enrollment: 25 (actual)

## Conditions studied

- Postoperative Confusion

## Interventions

- **DRUG:** Haloperidol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01862302
- **Lead sponsor:** McMaster University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2015-09
- **Final completion:** 2016-07
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2016-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01862302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01862302, "Haloperidol Prophylaxis in Cardiac Surgery for Patients at Risk for Delirium". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01862302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*